Drug class · Neurology & psychiatry
CNS stimulants Drug Codes & NDCs
Central nervous system stimulants, such as amphetamine and methylphenidate products. Many are DEA Schedule II.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Comfort-Timeacetaminophen, caffeine, and pyrilamine maleate | Acetaminophen 500 mg/1 + 2 more ingredients | Tablet, Film coatedOral | Time Cap Labs, Inc | 49483-347 |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 18 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-585 |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 36 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-586 |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 54 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-587 |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 27 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-588 |
| Cotempla XR-ODTmethylphenidate | Methylphenidate 8.6 mg/1 | Tablet, Orally disintegratingOral | Neos Therapeutics Brands, LLC | 70165-100 |
| Cotempla XR-ODTmethylphenidate | Methylphenidate 17.3 mg/1 | Tablet, Orally disintegratingOral | Neos Therapeutics Brands, LLC | 70165-200 |
| Cotempla XR-ODTmethylphenidate | Methylphenidate 25.9 mg/1 | Tablet, Orally disintegratingOral | Neos Therapeutics Brands, LLC | 70165-300 |
| Daytranamethylphenidate | Methylphenidate 10 mg/9h | PatchTransdermal | Noven Therapeutics, LLC | 68968-5552 |
| Daytranamethylphenidate | Methylphenidate 15 mg/9h | PatchTransdermal | Noven Therapeutics, LLC | 68968-5553 |
| Daytranamethylphenidate | Methylphenidate 20 mg/9h | PatchTransdermal | Noven Therapeutics, LLC | 68968-5554 |
| Daytranamethylphenidate | Methylphenidate 30 mg/9h | PatchTransdermal | Noven Therapeutics, LLC | 68968-5555 |
| Dexedrine Spansuledextroamphetamine sulfate | Dextroamphetamine sulfate 5 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-673 |
| Dexedrine Spansuledextroamphetamine sulfate | Dextroamphetamine sulfate 10 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-674 |
| Dexedrine Spansuledextroamphetamine sulfate | Dextroamphetamine sulfate 15 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-675 |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | 0093-5045 |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 35 mg/1 | Capsule, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | 0093-5046 |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | 0093-5550 |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | 0093-5551 |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | 0093-5552 |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | 0093-5553 |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | 0093-5554 |
| Dexmethylphenidate Hydrochloride | Dexmethylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | 0093-5562 |
| Dexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1709 |
| Dexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 35 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1710 |